4//SEC Filing
Robbins Andrew R 4
Accession 0000950170-25-009257
CIK 0001622229other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:56 PM ET
Size
5.4 KB
Accession
0000950170-25-009257
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-01-23+915,000→ 915,000 totalExercise: $8.89Exp: 2035-01-23→ Common Stock (915,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001590157
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:56 PM ET
- Size
- 5.4 KB